In addition, the upregulation of TMPO-AS1 is observed in MCF7-derived, tamoxifen-resistant cells (OHTR) and MCF7-derived LTED cells, which is associated with poor relapse-free survival in patients with breast cancer treated with tamoxifen [41]. The gene discussed is TMPO; the disease is breast carcinoma.